Actively Recruiting
Evaluation of Respiratory Trends During Blood Transfusions in Newborns
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2024-09-24
71
Participants Needed
1
Research Sites
2 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on newborn infants who require blood transfusions, aiming to study how their respiratory condition changes during these transfusions. The trial particularly examines complications like transfusion-associated cardiac overload (TACO) and transfusion-related acute lung injury (TRALI), which can affect the lungs and breathing. The study is important because respiratory transfusion reactions in newborns occur in about 8% of cases, especially in those with low birth weight and gestational age, but clear diagnostic criteria are lacking. Participants will undergo lung ultrasound examinations within six hours before and after their blood transfusions to detect fluid retention in the lungs and calculate a lung ultrasound score (LUS score). Oxygen saturation and fraction of inspired oxygen (SFR) levels will also be measured in this timeframe. For infants on respiratory support like nasal continuous positive airway pressure (nCPAP) or mechanical ventilation, ventilatory parameters such as mean airway pressure will be monitored before and after transfusions. Throughout the study, infants admitted for blood transfusions will be closely observed with these assessments to track any respiratory changes. Researchers will analyze lung ultrasound results, oxygen levels, and ventilation measures to identify respiratory trends and potential risk factors for worsening lung function related to transfusions. The study will continue until January 2026, with the primary outcomes focusing on changes in lung ultrasound scores and oxygenation within six hours around transfusions.
CONDITIONS
Brief Title
Respiratory Trends During Blood Transfusions in Newborns.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Admitted newborns requiring blood transfusions as per local practice and/or international guidelines
You will not qualify if you...
- Newborns with major malformations
- Need for palliative care
- Lack of informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Within hours of each blood transfusion
Participants undergo lung ultrasound examinations within 6 hours before and after blood transfusion to assess lung condition and calculate a lung ultrasound score.
2 visits per transfusion (before and after)
Trial Site Locations
Total: 1 location
1
Fondazione Policlinico Gemelli IRCCS
Roma, Italy, 00168
Actively Recruiting
Research Team
S
Stefano Nobile, MD, PhD, MSc
S
Stefano Nobile
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here